Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, we’ve seen interesting technologies being added to the spectrum of testing capabilities; hydroxychloroquine as a potential treatment seems to be falling from favour whilst remdesivir […]
Despite potential short-cuts, drug development is a lengthy and risky process that culminates in marketing approval. However, just because a drug achieves regulatory approval, does not mean that it will be instantly available to those in need. The complex journey for a pharmaceutical to gain patient access continues.
What is federated learning? Federated learning (FL) is a machine learning paradigm that allows to train algorithms collaboratively without the need for source data exchange between the parties. This means that different institutions or companies can join forces in the development of data-driven solutions without sharing their secrets. Participants in such a venture come together in an FL consortium. How […]